Dr. Nicole Arcentales, D.O

NPI: 1538314703
Total Payments
$23,676
2024 Payments
$2,907
Companies
57
Transactions
1,281
Medicare Patients
6,897
Medicare Billing
$725,256

Payment Breakdown by Category

Food & Beverage$23,255 (98.2%)
Other$320.00 (1.4%)
Education$100.75 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $23,255 1,270 98.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $320.00 5 1.4%
Education $100.75 6 0.4%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $3,849 163 $0 (2024)
ABBVIE INC. $2,304 113 $0 (2024)
Novo Nordisk Inc $2,202 136 $0 (2024)
PFIZER INC. $1,805 94 $0 (2024)
Lilly USA, LLC $1,544 99 $0 (2024)
Amgen Inc. $1,454 63 $0 (2024)
Merck Sharp & Dohme LLC $1,452 82 $0 (2024)
GlaxoSmithKline, LLC. $1,388 70 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $942.22 50 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $785.91 58 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,907 140 ABBVIE INC. ($512.66)
2023 $3,109 156 AbbVie Inc. ($712.93)
2022 $2,781 154 ABBVIE INC. ($418.28)
2021 $3,273 177 AbbVie Inc. ($609.55)
2020 $3,443 196 AstraZeneca Pharmaceuticals LP ($877.16)
2019 $2,893 154 AstraZeneca Pharmaceuticals LP ($815.98)
2018 $2,784 152 PFIZER INC. ($564.28)
2017 $2,486 152 Merck Sharp & Dohme Corporation ($325.46)

All Payment Transactions

1,281 individual payment records from CMS Open Payments — Page 1 of 52

Date Company Product Nature Form Amount Type
12/30/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $21.23 General
Category: Diabetes
12/20/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $22.19 General
Category: Respiratory
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.81 General
Category: Gastroenterology
12/18/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.63 General
Category: Inflammation
12/17/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $29.97 General
Category: PAIN
12/12/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $8.36 General
Category: Cardio-renal
12/09/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $109.75 General
Category: Bone Health
11/26/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.11 General
Category: Biological
11/21/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.41 General
Category: Cardio-renal
11/20/2024 PFIZER INC. PAXLOVID (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.21 General
Category: INFECTIOUS DISEASES
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.93 General
Category: Gastroenterology
11/19/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.10 General
Category: Respiratory
11/14/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $20.68 General
11/13/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $20.15 General
Category: Diabetes
11/12/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.10 General
Category: Inflammation
11/08/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.54 General
Category: Cardiology/Vascular Diseases
11/05/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $18.31 General
Category: ENDOCRINOLOGY
10/29/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.61 General
Category: RESPIRATORY
10/24/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $24.26 General
Category: Obesity
10/21/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $18.20 General
Category: NEUROSCIENCE
10/17/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $18.22 General
Category: Cardiology/Vascular Diseases
10/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.79 General
Category: Gastroenterology
10/15/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.27 General
Category: Cardiovascular and Metabolism
10/11/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.73 General
Category: Cardiovascular and Metabolism
10/09/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $16.00 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,804 2,081 $340,380 $189,999
2022 21 1,630 2,748 $294,296 $191,211
2021 22 1,622 3,023 $249,669 $182,745
2020 22 1,841 3,363 $233,805 $161,301
Total Patients
6,897
Total Services
11,215
Medicare Billing
$725,256
Procedure Codes
82

All Medicare Procedures & Services

82 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 454 454 $124,850 $67,637 54.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 363 490 $98,000 $50,967 52.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 186 245 $42,875 $17,501 40.8%
90662 Influenza vaccine split virus, preservative free Office 2023 177 177 $15,930 $12,732 79.9%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 41 41 $12,300 $11,555 93.9%
G0008 Administration of influenza virus vaccine Office 2023 224 225 $9,000 $8,096 90.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 31 31 $6,975 $5,924 84.9%
99496 Transitional care management services for problem of high complexity Office 2023 17 18 $5,040 $3,905 77.5%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 18 18 $3,600 $2,822 78.4%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 12 12 $3,000 $2,288 76.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $3,000 $1,705 56.8%
G0009 Administration of pneumococcal vaccine Office 2023 45 45 $1,800 $1,619 90.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 53 102 $3,570 $1,193 33.4%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 49 49 $4,165 $1,073 25.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 73 74 $5,550 $740.88 13.3%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 17 19 $380.00 $167.16 44.0%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 32 69 $345.00 $74.18 21.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 394 394 $71,895 $60,957 84.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 353 496 $92,600 $50,778 54.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 171 243 $39,325 $17,320 44.0%
J0897 Injection, denosumab, 1 mg Office 2022 11 840 $25,200 $14,343 56.9%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 36 36 $7,750 $7,171 92.5%
G0008 Administration of influenza virus vaccine Office 2022 171 171 $6,840 $6,035 88.2%
90662 Influenza vaccine split virus, preservative free Office 2022 87 87 $7,830 $5,963 76.2%
90682 Influenza vaccine, quadrivalent derived from recombinant dna Office 2022 74 74 $6,290 $5,072 80.6%

About Dr. Nicole Arcentales, D.O

Dr. Nicole Arcentales, D.O is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538314703.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicole Arcentales, D.O has received a total of $23,676 in payments from pharmaceutical and medical device companies, with $2,907 received in 2024. These payments were reported across 1,281 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($23,255).

As a Medicare-enrolled provider, Arcentales has provided services to 6,897 Medicare beneficiaries, totaling 11,215 services with total Medicare billing of $725,256. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Staten Island, NY
  • Active Since 12/01/2008
  • Last Updated 07/08/2010
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1538314703

Products in Payments

  • FARXIGA (Drug) $2,711
  • UBRELVY (Drug) $1,267
  • Kerendia (Drug) $942.22
  • TRULICITY (Drug) $858.09
  • TRELEGY ELLIPTA (Drug) $790.63
  • Ozempic (Drug) $732.54
  • VRAYLAR (Drug) $723.82
  • XIFAXAN (Drug) $642.55
  • BREZTRI (Drug) $609.42
  • JANUVIA (Drug) $568.38
  • CHANTIX (Drug) $527.77
  • Saxenda (Drug) $495.42
  • QULIPTA (Drug) $494.82
  • EVENITY (Biological) $468.24
  • Aimovig (Biological) $444.91
  • JARDIANCE (Drug) $423.75
  • SYMBICORT (Drug) $395.33
  • EUCRISA (Drug) $387.63
  • Vascepa (Drug) $369.92
  • NURTEC ODT (Drug) $354.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Staten Island